CCM
DFTX

Chiron Capital Management’s Definium Therapeutics DFTX Stock Holding History

Chiron Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
+7,000
New +$173K 0.3% 84

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FSBI
Fearless Solutions (Best Invest) San Antonio, Texas $189M AUM 32.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Chiron Capital Management's DFTX Position: Q2 2026 in Review

Chiron Capital Management opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 7,000 shares worth $329K. The stake represents 0.3% of the portfolio and ranks #84 among its holdings.

25 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Chiron Capital Management held 7,000 shares of Definium Therapeutics worth $329K as of Q2 2026.
  • Definium Therapeutics was a new Chiron Capital Management position in Q2 2026.
  • Definium Therapeutics made up 0.3% of Chiron Capital Management's portfolio in Q2 2026, its #84 holding.
  • 25 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.